Cigna Sees Elevated Cost Trends To Continue Into Next Year Cigna Group (NYSE:CI) reported second-quarter 2025 revenue of $67.13 billion on Thursday, beating analyst estimates of $62.46 billion. Benzinga · Jul 31, 2025
Centene, Cigna, Others Drop As Molina's Results Rattle Sector Molina Healthcare Inc. (NYSE:MOH) missed Wall Street expectations in its second-quarter earnings report Wednesday, triggering a selloff across the healthcare insurance sector. Benzinga · Jul 24, 2025
Cigna Group's Q2 2025 Earnings: What to Expect Cigna Group is expected to release its fiscal second-quarter earnings later this month, and analysts project a single-digit earnings growth. Barchart · Jul 14, 2025
How Is Cigna Group’s Stock Performance Compared to Other Healthcare Providers Stocks? Cigna Group has outperformed the Healthcare Providers industry over the past year, and analysts are highly optimistic about the stock’s prospects. Barchart · Jun 3, 2025
The Cigna Group Stock Outlook: Is Wall Street Bullish or Bearish? The Cigna Group has struggled to keep pace with the broader market over the past year, yet Wall Street remains highly optimistic on its future prospects. Barchart · May 14, 2025
Cigna Group Earnings Preview: What to Expect Cigna Group is expected to release its fiscal first-quarter results next month, and analysts foresee a modest single-digit drop in earnings. Barchart · Apr 22, 2025
Dead Man's Body Placed in Frozen Chamber With Hopes of Being Brought Back to Life in the Future The dead body of a British man has been placed in "long-term cryonic storage" in Michigan, leaving open the possibility of potential revival. Latin Times · Apr 3, 2025
Cigna Group Stock: Is CI Outperforming the Healthcare Sector? Due to Cigna Group’s outperformance relative to its healthcare sector on a YTD basis, Wall Street analysts maintain bullish about the stock’s prospects. Barchart · Mar 7, 2025
Are Wall Street Analysts Predicting The Cigna Group Stock Will Climb or Sink? The Cigna Group observed a notable drop in earnings in the recent quarter and has continued to underperform other healthcare services stocks over the past year. Yet, analysts remain strongly bullish on the stock’s prospects. Barchart · Feb 12, 2025
Cigna Misses EPS: What It Means for the Health Insurance Industry Cigna is one of the most efficiently managed health insurance companies evidenced by its foresight to sell its Medicare Advantage business before the fallout. MarketBeat · Feb 4, 2025
What to Expect From Cigna Group's Next Quarterly Earnings Report Cigna Group is scheduled to release its fiscal fourth-quarter and fiscal 2024 earnings next month, and analysts anticipate its bottom line to rise in a modest single digit. Barchart · Jan 16, 2025
How Cigna Remains at the Top of the Health Insurance Food Chain The Cigna Group has been agile and nimbly navigating the trends in managed care as it unloaded its Medicare Advantage business before the storm hit its peers. MarketBeat · Jan 6, 2025
3 Highly-Rated Dividend Stocks To Buy on the Dip Discover 3 top income stocks with low payout ratios, strong buy ratings, and long-term growth potential. Barchart · Dec 21, 2024
Is Cigna Group Stock Underperforming the Dow? Despite Cigna Group’s recent underperformance relative to the Dow, Wall Street analysts remain strongly optimistic about the stock’s prospects. Barchart · Dec 6, 2024
StockNews.com · Dec 2, 2024 3 Undervalued Healthcare Stocks With Upside Potential The healthcare industry thrives due to novel drug pipeline discoveries, AI integration to streamline processes and technological advancements. So, investing in undervalued healthcare stocks with upside potential, Pfizer (PFE), Cigna Group (CI), and Centene Corp (CNC), could be a wise idea. Keep reading….
Barchart · Nov 19, 2024 Is Wall Street Bullish or Bearish on Cigna Group Stock? Cigna Group has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.
StockNews.com · Nov 6, 2024 3 Healthcare Stocks for Long-Term Stability and Growth With the rise of chronic diseases, technological advances and innovative drug pipelines are driving significant growth in the healthcare industry. Hence, investors may find long-term stability and exciting opportunities by adding stocks, Johnson & Johnson (JNJ), Pfizer (PFE), and Cigna Group (CI), to their portfolios. Read more….
Barchart · Oct 22, 2024 What to Expect From Cigna Group's Q3 2024 Earnings Report Cigna Group is set to announce its fiscal third-quarter earnings next week, and analysts anticipate a modest single-digit profit increase.
Barchart · Oct 1, 2024 What to Expect From UnitedHealth’s Next Quarterly Earnings Report UnitedHealth will release its third-quarter earnings this month, and analysts anticipate a single-digit bottom-line growth.
StockNews.com · Sep 26, 2024 3 Growth Stocks Wall Street Loves for 2024 Investing in growth stocks is appealing due to attractive pricing, stable business activity, easing inflation, and the Fed's gradual rate cuts, all of which create a favorable environment for capital gains. With a positive global economic outlook, it could be wise to consider investing in stocks that Wall Street loves…
StockNews.com · Sep 6, 2024 3 Health Insurance Stocks to Watch as Healthcare Costs Rise With rising medical costs and an expanding aging population, the health insurance sector is set to witness significant growth. Hence, investors looking to capitalize on this trend could consider stable health insurance stocks Elevance Health (ELV), Cigna Group (CI), and Centene (CNC). Read on….
StockNews.com · Sep 5, 2024 3 Undervalued Healthcare Stocks With Strong Upside Potential The healthcare sector is set for robust growth, driven by surging demand for quality treatments, a growing patient base, breakthroughs in biopharma, and supportive policies. Therefore, investors could consider undervalued pharmaceutical stocks like Merck & Co. (MRK), Pfizer (PFE), and Cigna (CI) with significant upside potential. Read more.
Barchart · Sep 5, 2024 Is The Cigna Group Stock Outperforming the Nasdaq? The Cigna Group has outperformed the Nasdaq Composite over the past year and analysts remain bullish about the stock’s prospects.
StockNews.com · Aug 14, 2024 3 Blue-Chip Stocks With Strong Buy Ratings Blue-chip stocks offer stability and consistent growth irrespective of market conditions. Thus, blue chip names Lockheed Martin (LMT), Regeneron Pharmaceuticals (REGN), and Cigna Group (CI) could be prudent additions to your portfolios. These stocks are Strong Buy-rated in our proprietary POWR Ratings system. Read on.
Barchart · Aug 13, 2024 Are Wall Street Analysts Bullish on Cigna Group Stock? Cigna Group has underperformed the broader market over the past year, but Wall Street analysts are optimistic about the stock’s prospects.